A Randomised Single Blind Study Comparing the Molar ED50 of Levobupivacaine and Molar ED50 of Ropivacaine When Administered as a Femoral Perineural Infusion for Pain Relief After Total Knee Replacement.

Trial Profile

A Randomised Single Blind Study Comparing the Molar ED50 of Levobupivacaine and Molar ED50 of Ropivacaine When Administered as a Femoral Perineural Infusion for Pain Relief After Total Knee Replacement.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2015

At a glance

  • Drugs Levobupivacaine (Primary) ; Ropivacaine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Mar 2012 Primary endpoint identified as (Verbal rating scale) as reported by European Clinical Trials Database record.
    • 23 Nov 2011 Location (Scotland) added as reported by ClinicalTrials.gov.
    • 23 Nov 2011 Company Tenovus added in associations field as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top